Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
The Surgical Clinics of North America|July 15, 2018
Evolution of Operative Technique for MastectomyCaroline Jones, Rachael LancasterCurrent Problems in Diagnostic Radiology|July 27, 2021
From the Reading Room to Operating Room: Retrospective Data and Pictorial Review After 806 SCOUT PlacementsKasey Cooper, Elizabeth Allen, Rachael Lancaster, et al.The Journal of Surgical Research|December 4, 2018
The Impact of Breast Lumpectomy Tray Utilization on Cost SavingsEmily Malone, Jason Baldwin, Joshua Richman, et al.American Journal of Surgery|December 20, 2023
When I Don't see me, Am I seen? Race and student perception of the surgery clerkshipPolina Zmijewski, Carla Aleman, Chandler McLeod, et al.American Journal of Surgery|May 8, 2024
Resident perspectives on the role of gender in operative experience during general surgery residency training: A mixed-methods studyLeah K Winer, Nicole Panzica, Kenneth Lynch, et al.Frontiers in Oncology|July 26, 2022
Feasibility and Short-Term Toxicity of a Consecutively Delivered Five Fraction Stereotactic Body Radiation Therapy Regimen in Early-Stage Breast Cancer Patients Receiving Partial Breast IrradiationYilan Liu, Christopher Veale, Diana Hablitz, et al.Annals of Surgical Oncology|July 12, 2024
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical TrialKayla M Switalla, Judy C Boughey, Katrina Dimitroff, et al.Annals of Surgical Oncology|July 24, 2025
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical TrialRita A Mukhtar, Katrina Dimitroff, Christina Yau, et al.JAMA Surgery|September 7, 2022
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 TrialMarie Osdoit, Christina Yau, W Fraser Symmans, et al.JAMA Internal Medicine|December 12, 2025
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical TrialKirkpatrick B Fergus, Katherine S Ross, Maren T Scheuner, et al.Pageof 2